U10
UBIQUINONE-10
Find entries where: U10
is present as a standalone ligand in 201 entries
as a non-polymer is covalently linked to polymer or other heterogen groups 5 entries
Chemical Component Summary | |
---|---|
Name | UBIQUINONE-10 |
Synonyms | Coenzyme Q10 |
Identifiers | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methyl-cyclohexa-2,5-diene-1,4-dione |
Formula | C59 H90 O4 |
Molecular Weight | 863.343 |
Type | NON-POLYMER |
Isomeric SMILES | CC1=C(C(=O)C(=C(C1=O)OC)OC)C\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C |
InChI | InChI=1S/C59H90O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61/h24,26,28,30,32,34,36,38,40,42H,15-23,25,27,29,31,33,35,37,39,41,43H2,1-14H3/b45-26+,46-28+,47-30+,48-32+,49-34+,50-36+,51-38+,52-40+,53-42+ |
InChIKey | ACTIUHUUMQJHFO-UPTCCGCDSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 153 |
Chiral Atom Count | 0 |
Bond Count | 153 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB09270 |
---|---|
Name | Ubidecarenone |
Groups |
|
Description | Ubidecarenone, also called coenzyme Q10, is a 1,4-benzoquinone. From its name (Q10), the Q refers to the constitutive quinone group, and 10 is related to the number of isoprenyl subunits in its tail.[A7874] It is a powerful antioxidant, a lipid-soluble and essential cofactor in mitochondrial oxidative phosphorylation.[A31413] The ubidecarenone is the coenzyme destined for mitochondrial enzyme complexes involved in oxidative phosphorylation in the production of ATP. It is fundamental for cells that have a high metabolic demand.[L1062] Ubidecarenone is sold as a dietary supplement and is not FDA approved as a drug - it is not meant to treat, cure or prevent any disease. FDA does not approve this dietary supplements before sold nor regulate the manufacturing process.[L1063] |
Synonyms |
|
Brand Names |
|
Indication | The diet supplements containing ubidecarenone are indicated, as stated in the product label, to assist individuals with cardiovascular complaints including congestive heart failure and systolic hypertension. In the product, ubidecarenone is used to increase the cardiac input as well as for the prevention of several other diseases like Parkinson, fibromyalgia, migraine, periodontal disease and diabetes, based on preclinical studies.[L1064] It is important to highlight that these products are not FDA approved and it is recommended to use under discretion. |
Categories |
|
ATC-Code | C01EB09 |
CAS number | 303-98-0 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial | MAAPCLLRQGRAGALKTMLQEAQVFRGLASTVSLSAESGKSEKGQPQNSK... | unknown | cofactor |
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | MSGVRGLSRLLSARRLALAKAWPTVLQTGTRGFHFTVDGNKRASAKVSDS... | unknown | cofactor |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | MLSRLFRMHGLFVASHPWEVIVGTVTLTICMMSMNMFTGNNKICGWNYEC... | unknown | substrate |
Low-density lipoprotein receptor | MGPWGWKLRWTVALLLAAAGTAVGDRCERNEFQCQDGKCISYKWVCDGSA... | unknown | substrate |
Very low-density lipoprotein receptor | MGTSALWALWLLLALCWAPRESGATGTGRKAKCEPSQFQCTNGRCITLLW... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 5281915 |
ChEMBL | CHEMBL454801 |
ChEBI | CHEBI:46245 |